Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...

We estimate that MRD represents a $20+ billion addressable market, growing at 30% annually, which we believe is less than 10% penetrated NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...

When it comes to residual values, there’s a new king — two of them, actually. After four consecutive years on top, Honda and Lexus have ceded their crowns to Toyota and Tesla, which were named as best ...

In patients with newly diagnosed multiple myeloma (MM) who are not eligible for stem cell transplant, the regimen of isatuximab plus lenalidomide, dexamethasone, and bortezomib (also known as Isa-VRd) ...

Dec 10 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

Dec 10 (Reuters) - A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial treatments, potentially allowing patients to avoid ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

To fulfill the 2 Core Courses, take two Core Courses from two different Core Areas. Computational Data Science (CDS) Core Courses are classified into five areas: Data Analytics and Visualization, Data ...

ABSTRACT: This study investigates the impact of wage structure on employee satisfaction, motivation, and retention in Thailand’s textile manufacturing industry. Despite the recognized importance of ...

Bitcoin remained closer to “oversold” during its latest all-time highs, according to the Mayer Multiple, which suggested a potential price target of $180,000. Bitcoin’s Mayer Multiple suggests that ...